These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6173689)

  • 1. Antiproliferative assay for human interferons.
    Slimmer S; Masui H; Kaplan NO
    Methods Enzymol; 1981; 79(Pt B):419-22. PubMed ID: 6173689
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon, preclinical basis for clinical trials with fibroblast interferon in Japan.
    Kataoka T; Sakurai Y; Ida N; Kobayashi S
    Cancer Treat Rev; 1980 Dec; 7(4):253-6. PubMed ID: 6163536
    [No Abstract]   [Full Text] [Related]  

  • 3. Noncycling tumor cells are sensitive targets for the antiproliferative activity of human interferon.
    Horoszewicz JS; Leong SS; Carter WA
    Science; 1979 Nov; 206(4422):1091-3. PubMed ID: 493995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor effects of interferon and its possible use as an anti-neoplastic agent in man.
    Strander H
    Tex Rep Biol Med; 1977; 35():429-35. PubMed ID: 358466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay of growth inhibition in lymphoblastoid cell cultures.
    Evinger M; Pestka S
    Methods Enzymol; 1981; 79(Pt B):362-8. PubMed ID: 6173685
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological properties of natural and recombinant interferons.
    Pestka S; Evinger M; Maeda S; Rehberg E; Familletti PC; Kelder B
    Tex Rep Biol Med; 1981-1982; 41():31-6. PubMed ID: 6184819
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiviral and antiproliferative activity of human interferons and their induction of 2',5'-oligoadenylate synthetase].
    Krispin TI; Itkes AV; Balandin IG; Solov'eva MF; Kuznetsov VP
    Mol Gen Mikrobiol Virusol; 1986 Apr; (4):42-6. PubMed ID: 2432419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
    Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
    J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interferon on the human clonal cell line, RSa: inhibition of macromolecular synthesis.
    Fuse A; Kuwata T
    J Gen Virol; 1976 Oct; 33(1):17-24. PubMed ID: 978184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon therapy: pharmacokinetic and pharmacological aspects.
    Billiau A
    Arch Virol; 1981; 67(2):121-33. PubMed ID: 6163417
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of the recreational agent isobutyl nitrite on human peripheral blood leukocytes and on in vitro interferon production.
    Hersh EM; Reuben JM; Bogerd H; Rosenblum M; Bielski M; Mansell PW; Rios A; Newell GR; Sonnenfeld G
    Cancer Res; 1983 Mar; 43(3):1365-71. PubMed ID: 6186374
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of the antiviral and antiproliferative activity of human interferon preparations obtained in suspension and stationary cultures of donor leukocytes].
    Timofeev IV; Kuznetsov VP; Mekhedov LN; Nikolaeva TG; Orlova TG
    Antibiotiki; 1981 Sep; 26(9):703-5. PubMed ID: 6170254
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiproliferative and antiviral activities of human leukocyte interferons.
    Evinger M; Rubinstein M; Pestka S
    Arch Biochem Biophys; 1981 Aug; 210(1):319-29. PubMed ID: 6170263
    [No Abstract]   [Full Text] [Related]  

  • 14. High throughput screening for identification of RANTES chemokine expression inhibitors.
    Barnes DA; Jones SW; Perez HD
    Methods Enzymol; 1997; 287():292-304. PubMed ID: 9330329
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacological aspects of interferon therapy in man.
    Billiau A
    Acta Microbiol Acad Sci Hung; 1981; 28(3):257-62. PubMed ID: 6171139
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiviral and anticellular activity of human leukocytic and fibroblastic interferons in homo- and heterologous cells].
    Orlova TG; Zhdanov LV; Timofeev IV; Indikova IN; Mentkevich LM
    Vopr Virusol; 1981; (4):404-7. PubMed ID: 6171095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel dual-reporter preclinical screen for antiastrocytoma agents identifies cytostatic and cytotoxic compounds.
    Hawes JJ; Nerva JD; Reilly KM
    J Biomol Screen; 2008 Sep; 13(8):795-803. PubMed ID: 18664715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach for examining the anti-proliferative effect of protein kinase C inhibitors against human astrocytoma cells.
    Sharif TR; Sharif M
    Int J Oncol; 1998 Oct; 13(4):685-92. PubMed ID: 9735396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferons in cancer therapy: a reappraisal.
    Balkwill FR; Smyth JF
    Lancet; 1987 Aug; 2(8554):317-9. PubMed ID: 2441217
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interferon effects on the levels of ornithine decarboxylase activity in Friend cells].
    Capobianchi MR; Rossi GB; Dolei A
    Ann Ist Super Sanita; 1982; 18(3):409-11. PubMed ID: 6198945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.